Skip to Main Content

WASHINGTON — Raj Panjabi has made a career out of taking on some of public health’s toughest challenges, from malaria to Ebola to Covid-19 to mpox.

Panjabi’s next act will be leading a team at Flagship Pioneering. That team, which is focused on preventative medicine, has been around for three years.

advertisement

The group could grow under four main categories, Panjabi said: preparing for infectious disease threats, delaying the onset of disease, biosecurity, and pursuing bolder early treatments for diseases with public health consequences like obesity, cancer, and neurodegenerative illnesses.

STAT+ Exclusive Story

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect

To submit a correction request, please visit our Contact Us page.